Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient surv
about
RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer geneEpidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix- and proteolysis-dependent increase in persistence.BTECH: a platform to integrate genomic, transcriptomic and epigenomic alterations in brain tumorsPhase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data.Dual functions of NME1 in suppression of cell motility and enhancement of genomic stability in melanomaPDGF induced microRNA alterations in cancer cells.The metastasis suppressor NME1 regulates expression of genes linked to metastasis and patient outcome in melanoma and breast carcinoma.Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.PDGF-A promoter and enhancer elements provide efficient and selective antineoplastic gene therapy in multiple cancer types3-Deoxyschweinfurthin B Lowers Cholesterol Levels by Decreasing Synthesis and Increasing Export in Cultured Cancer Cell Lines.Systematic identification of transcription factors associated with patient survival in cancers.Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies.Heterogeneous activation of the TGFbeta pathway in glioblastomas identified by gene expression-based classification using TGFbeta-responsive genes.
P2860
Q24305480-C9151856-1317-43D3-840A-0B95AF4C5C9DQ30483791-33C0BB3D-2536-4909-9203-66F15877F317Q30484798-51229139-B396-495B-AC87-A1E2F4B09C48Q33388438-0E65DC73-9917-455A-9CFF-C8BA8BA7A8A3Q33538943-3281B1EF-C59F-46F1-83E4-EBCC6F60CDE6Q34964472-80D28F7F-D83B-49F1-B94E-72F0D27BAAC3Q35017837-5A635E43-8C66-4832-872E-2F7984D3C6BDQ35536511-1D6F9471-3F2D-4C22-BD8E-DCA33ED84961Q36926767-23D386C5-65CB-4141-B56E-5FD7753D6EB5Q37314570-4205C280-999D-4167-92CF-47E332C1A6ADQ37587640-087208CC-2CE5-4B7E-8523-43602CEDFC55Q38354101-E34DF829-6B23-49EF-A60E-FBE21ADCFF20Q39214217-64FB4FD9-93F6-466C-9C51-780180CF99A5Q43163564-414ED5E5-D337-4B29-9BB2-959A00CA6A27
P2860
Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient surv
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Autocrine platelet-derived gro ...... ered genotype and patient surv
@en
type
label
Autocrine platelet-derived gro ...... ered genotype and patient surv
@en
prefLabel
Autocrine platelet-derived gro ...... ered genotype and patient surv
@en
P2093
P1433
P1476
Autocrine platelet-derived gro ...... ered genotype and patient surv
@en
P2093
Catherine L Nutt
David M Kaetzel
David N Louis
Piam Shanehsaz
Xuejun Peng
P304
P356
10.1158/0008-5472.CAN-04-2582
P407
P577
2005-07-01T00:00:00Z